Ready for your COVID-19 Vaccine?
Concerned you have COVID-19?
Coronavirus | Covid-19 Vaccines

Recently, Missouri and Illinois announced the next phase of their COVID-19 vaccine plans which include certain members of the public as outlined by the states.

As of February 25, BJC HealthCare has:

  • Vaccinated over 72,000 eligible individuals
  • Opened two public vaccination clinics
  • Pre-registered more than 332,000 people to receive vaccines

We are committed to vaccinating our community! Please be patient with us as we work around these issues:

VACCINE SUPPLY. Our weekly state allocation is between 5,000-6,000 doses.

HIGH NUMBER OF CAREGIVERS. Under state and federal guidelines, we first vaccinated our health care providers. As the state’s largest employer, BJC and Washington University School of Medicine have a large population of caregivers.

STATE AND FEDERAL GUIDELINES. BJC is committed to following all government regulations as we provide this vital care to our community.

COVID-19 Vaccines

 

BJC HealthCare and Washington University are working quickly to make the COVID-19 vaccine available to those who are eligible in accordance with federal and state guidelines. We strongly encourage the vaccine for anybody who is eligible to receive it.

The vaccine will be distributed in a series of phases developed by the Centers for Disease Control and Prevention (CDC) and implemented at a state level. Decisions about the distribution phases and timelines are made by U.S. and state public health agencies, with a goal of providing the vaccine first to those believed to be at highest risk. More information about the distribution phases can be found below.

Active Vaccination Priority Phases

Currently the active phases for Missouri and Illinois are:

Pre-register for Your Vaccination
  • You do not need to be a current patient of BJC HealthCare or Washington University to register for and receive a COVID-19 vaccine. If you are not currently a patient, please indicate that when you pre-register.
  • You may still pre-register for the vaccine even if your group is not yet eligible.
  • You must be a current resident of Missouri or Illinois in order to receive the vaccine from BJC.

What Next?

We will contact you when your eligibility window opens, and when vaccine supply and distribution capacity are available. There are several pre-registration websites through counties and other health systems. You may pre-register on multiple sites. We recommend that you accept the first opportunity provided to receive a vaccine.

It could be several weeks, or even months, before you are able to schedule. We appreciate your patience.

Vaccines will be scheduled through our patient portal, MyChart. We will follow up with guidance on accessing MyChart. This will enable a smoother process when it is time to schedule your vaccine.

Learn more about COVID-19 and the vaccine.

What are mRNA vaccines?

Both the Pfizer and Moderna COVID-19 vaccines are mRNA vaccines. But, how do mRNA vaccines work?

Read More

Five things you should know about getting a COVID-19 vaccine

Our experts discuss how to pre-register for the vaccine and what to do after you receive it.

Read More

COVID-19 vaccine side effects

The FDA granted Emergency Use Authorizations (EUA) after the vaccines were shown to be safe and effective, based on data from the manufacturers and the findings from clinical trials involving some 74,000 people.

Read More

Timeline of the COVID-19 vaccine development

Each year, millions of vaccines to prevent infectious diseases are given to infants, children, adolescents and adults — and it’s critical that they are safe and effective.

Read More

COVID-19 vaccine safety, availability and delivery

With all of the uncertainty surrounding the vaccine, we have answered some of the most frequently asked questions with the latest information available. The answers to these questions will continue to be updated as we know more.

Read More

COVID-19 Vaccine Availability in Missouri and Illinois

After nine months of a devastating pandemic, there are finally encouraging developments toward controlling COVID-19.

Read More